World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
8728
World Ranking
4765
National Ranking
2139

Urszula Krzych publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Urszula Krzych sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 116 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Urszula Krzych D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Urszula Krzych sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Urszula Krzych is affiliated with the United States Army Research Laboratory in the United States and has contributed extensively to research in medicine, immunology, and microbiology. Their work concentrates on several subfields, including public health, environmental and occupational health, immunology, epidemiology, virology, and parasitology.

The primary research topics addressed in their publications include malaria research and control, the complement system in diseases, mosquito-borne diseases and control, hepatitis B virus studies, immunotherapy and immune responses, HIV research and treatment, and parasites and host interactions.

Krzych has published research in several scientific venues, with frequent publications in:

  • Critical Reviews in Immunology
  • The Journal of Immunology
  • Infection and Immunity
  • Vaccine
  • European Journal of Immunology

Their recent papers include:

  • Plasmodium Preerythrocytic Vaccine Antigens Enhance Sterile Protection in Mice Induced by Circumsporozoite Protein, 2021, Infection and Immunity
  • A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults, 2024, Vaccine
  • The Form of an Antigen and Its Molecular Context Do Matter: Infectious versus Attenuated Plasmodium Sporozoites, 2020, Critical Reviews in Immunology
  • Eli's Propinquity is Far Reaching, from Escherichia coli β-Galactosidase to the Plasmodium Parasite, 2020, Critical Reviews in Immunology
  • Prime-Trap immunization with protective liver stage antigen, MIF-4G and Kb17 peptide, induces liver CD8 TRM cells and protection against Plasmodium berghei malaria, 2021, The Journal of Immunology

Krzych has collaborated frequently with several coauthors, including:

  • Alexander Pichugin
  • Nouf Althubaiti
  • Patrick E. Duffy
  • Jonathan P. Renn
  • Sarat K. Dalai

Their multi-disciplinary research intersects infectious disease immunology and vaccine development, especially focusing on malaria and mosquito-borne diseases. The work contributes to understanding antigen forms in vaccine efficacy and the immune response in liver-stage malaria protection.

Best Publications

  • A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

    J A Stoute;M Slaoui;D G Heppner;P Momin

  • Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

    Kent E. Kester;James F. Cummings;Opokua Ofori-Anyinam;Christian F. Ockenhouse

  • Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

    D. M. Gordon;T. W. McGovern;U. Krzych;J. C. Cohen

  • Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

    Kent E. Kester;Denise A. McKinney;Nadia Tornieporth;Christian F. Ockenhouse

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Long-Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine

    J A Stoute;K E Kester;U Krzych;B T Wellde

  • The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site.

    G. Gammon;Nilabh Shastri;J. Cogswell;S. Wilbur

  • Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ

    Peifang Sun;Robert Schwenk;Katherine White;Jose A. Stoute

  • Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

    D. Gray Heppner;Kent E. Kester;Christian F. Ockenhouse;Nadia Tornieporth

  • Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

    Michele D. Spring;James F. Cummings;Christian F. Ockenhouse;Sheetij Dutta

  • Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design

    Kelley M. VanBuskirk;Matthew T. O'Neill;Patricia De La Vega;Alexander G. Maier

  • Genetically Attenuated Plasmodium berghei Liver Stages Induce Sterile Protracted Protection That Is Mediated by Major Histocompatibility Complex Class I-Dependent Interferon-γ-Producing CD8+ T Cells

    Ousman Jobe;Joanne Lumsden;Ann-Kristin Mueller;Jackie Williams

  • First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers.

    Michele Spring;Jittawadee Murphy;Robin Nielsen;Megan Dowler

  • Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.

    Kent E. Kester;James F. Cummings;Christian F. Ockenhouse;Robin Nielsen

  • A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

    Kent E. Kester;Denise A. Mckinney;Nadia Tornieporth;Christian F. Ockenhouse

  • T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens.

    U Krzych;J A Lyon;T Jareed;I Schneider

  • Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

    Mark E. Polhemus;Mark E. Polhemus;Alan J. Magill;James F. Cummings;Kent E. Kester

  • Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine.

    L.S Rickman;R Wistar;S.L Hoffman;D.M Gordon

  • Reduced Cord Blood Immune Effector-Cell Responsiveness Mediated by CD4 + Cells Induced in Utero as a Consequence of Placental Plasmodium falciparum Infection

    Kim Brustoski;Kim Brustoski;Ulrike Möller;Martin Kramer;Franca C. Hartgers

  • Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection

    James F. Cummings;Michele D. Spring;Robert J. Schwenk;Christian F. Ockenhouse

Frequent Co-Authors

Kent E. Kester
Kent E. Kester Walter Reed Army Institute of Research
D. Gray Heppner
D. Gray Heppner Crozet BioPharma
W. Ripley Ballou
W. Ripley Ballou International AIDS Vaccine Initiative
Joe Cohen
Joe Cohen GlaxoSmithKline (United Kingdom)
Christian F. Ockenhouse
Christian F. Ockenhouse Walter Reed Army Institute of Research
David E. Lanar
David E. Lanar Walter Reed Army Institute of Research
Patrick E. Duffy
Patrick E. Duffy National Institute of Allergy and Infectious Diseases
Carl R. Alving
Carl R. Alving Walter Reed Army Institute of Research
Stefan H. I. Kappe
Stefan H. I. Kappe University of Washington
Adrian J. F. Luty
Adrian J. F. Luty Institut de Recherche pour le Développement

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open doors to diverse career options. One popular route is pursuing nurse practitioner programs, where flexibility and quality vary significantly. Students often look for easiest online nurse practitioner programs to balance education with personal commitments.

Mental health is another critical area connected to Immunology studies, especially for those aiming to specialize in psychiatric care. Programs like the best pmhnp programs emphasize clinical experience, ensuring graduates are job-ready in high-demand fields.

Affordability is key for many students. Identifying the cheapest psych np programs allows future healthcare professionals to gain quality education without overwhelming debt, making advanced degrees accessible to a broader audience.

Finally, understanding the financial outlook of different specialties helps in career planning. The highest paid dnp specialties information highlights lucrative paths for Doctor of Nursing Practice graduates, making it easier to align passion with earning potential.

Best Scientists Citing Urszula Krzych

Trending Scientists

Recently Published Articles